Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Vascular disrupting agent
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
ABT-751
/ AbbVie, Eisai
BNC105
/ Bionomics
Azixa
(verubulin) / Immune Pharma
lexibulin
(CYT997) / Gilead
combretastatin A1 di-phosphate
(OXi4503) / Oncotelic
valecobulin
(CKD-516) / Chong Kun Dang
SB01
/ Sinphar Pharma
lisavanbulin
(BAL101553) / Basilea
Kominox
(sodium metaarsenite) / Komipharm
OC-10X
/ OcuCure Therap
crolibulin
(EPC2407) / Immune Pharma
AGI-101H
/ National Cancer Institute
